What To Expect From BioXcel Therapeutics Inc (BTAI) Q3 2024 …

Nov 13, 2024 · BioXcel Therapeutics Inc (NASDAQ:BTAI) is set to release its Q3 2024 earnings on Nov 14, 2024. The consensus estimate for Q3 2024 revenue is $1.31 million, and the …

CouponFollow Extension

$1.31
OFF

What To Expect From BioXcel Therapeutics Inc (BTAI) Q3 2024 …

6 days from now

Nov 13, 2024 · BioXcel Therapeutics Inc (NASDAQ:BTAI) is set to release its Q3 2024 earnings on Nov 14, 2024. The consensus estimate for Q3 2024 revenue is $1.31 million, and the …

yahoo.com

89%
OFF

BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings Call Highlights ...

6 days from now

Nov 15, 2024 · BioXcel Therapeutics Inc (NASDAQ:BTAI) reported an 89% increase in net revenue for the nine months ended September 30, 2024, compared to the same period in …

yahoo.com

$13
OFF

BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript

6 days from now

Nov 14, 2024 · BioXcel Therapeutics had a net loss of $13.7 million for the third quarter of 2024, compared to a net loss of $50.5 million for the same period in 2023. Company used $16.3 …

seekingalpha.com

34%
OFF

What To Expect From BioXcel Therapeutics Inc (BTAI) Q3 2024 Earn

6 days from now

After releasing the results, BioXcel Therapeutics Inc (BTAI) was up by 4.34% in one day. BioXcel Therapeutics Inc (BTAI, Financial) 12 Month Price Targets. Based on the one-year price …

gurufocus.com

$179.05
OFF

BioXcel Therapeutics (BTAI) Earnings Date And Reports 2024

6 days from now

5 days ago · BioXcel Therapeutics (NASDAQ:BTAI) has a recorded net income of -$179.05 million. BTAI has generated -$2.16 earnings per share over the last four quarters. What is …

marketbeat.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

1 day ago · BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript BioXcel announces common stock and warrants offering, no amount given BioXcel Therapeutics …

seekingalpha.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence …

bioxceltherapeutics.com

$0.58
OFF

BioXcel Therapeutics Stock Price | BTAI Stock Quote, News, And …

6 days from now

On Wednesday 11/20/2024 the closing price of the BioXcel Therapeutics Inc Registered Shs share was $0.58 on BTT. Compared to the opening price on Wednesday 11/20/2024 on BTT …

businessinsider.com

FAQs about What To Expect From BioXcel Therapeutics Inc (BTAI) Q3 2024 … Coupon?

When will bioxcel Therapeutics Inc (btai) release its Q3 2024 earnings?

BioXcel Therapeutics Inc (NASDAQ:BTAI) is set to release its Q3 2024 earnings on Nov 14, 2024. The consensus estimate for Q3 2024 revenue is $1.31 million, and the earnings are expected to come in at -$0.60 per share. The full year 2024's revenue is expected to be $4.70 million and the earnings are expected to be -$2.30 per share. ...

What time will bioxcel Therapeutics' financial results be released?

Conferencecallset for 8:00a.m.ETtoday NEW HAVEN, Conn., Nov. 14, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced its financial results for the third quarter of 2024. ...

What did bioxcel Therapeutics report in third quarter 2024?

BioXcel Therapeutics Reports Third Quarter 2024 Financial Results BioXcel Therapeutics Thu, Nov 14, 2024, 7:00 AM13 min read In This Article: BTAI BioXcel Therapeutics Advancing two pivotal Phase 3 trials of BXCL501 for acute treatment of agitation associated with bipolar disorders, schizophrenia, and Alzheimer’s dementia ...

What is the target price for bioxcel Therapeutics Inc (btai)?

After releasing the results, BioXcel Therapeutics Inc (NASDAQ:BTAI) was up by 4.34% in one day. Based on the one-year price targets offered by 6 analysts, the average target price for BioXcel Therapeutics Inc (NASDAQ:BTAI) is $6.50 with a high estimate of $18 and a low estimate of $1. ...

Is bioxcel Therapeutics a biopharmaceutical company?

NEW HAVEN, Conn., Nov. 14, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced its financial results for the third quarter of 2024. ...

How do I contact bioxcel Therapeutics?

Visit www.fda.gov/medwatchor call 1-800-FDA-1088. You can also contact BioXcel Therapeutics, Inc. at 1-833-201- 1088 or [email protected]. Please see full Prescribing Information. About BXCL501 ...